Cite
Wang C, Jing ZC, Huang YG, et al. Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison. Heart Asia. 2016;8(1):74-82doi: 10.1136/heartasia-2015-010712.
Wang, C., Jing, Z. C., Huang, Y. G., Zhou, D. X., Liu, Z. H., Meier, C., Nikkho, S., Curram, J., Zhang, P., & He, J. G. (2016). Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison. Heart Asia, 8(1), 74-82. https://doi.org/10.1136/heartasia-2015-010712
Wang, Chen, et al. "Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison." Heart Asia vol. 8,1 (2016): 74-82. doi: https://doi.org/10.1136/heartasia-2015-010712
Wang C, Jing ZC, Huang YG, Zhou DX, Liu ZH, Meier C, Nikkho S, Curram J, Zhang P, He JG. Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison. Heart Asia. 2016 May 17;8(1):74-82. doi: 10.1136/heartasia-2015-010712. eCollection 2016. PMID: 27326239; PMCID: PMC4898635.
Copy
Download .nbib